| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/01/2009 | EP2073830A1 Interferon type i supporting compounds |
| 07/01/2009 | EP2073829A2 Stabilized therapeutic small helical antiviral peptides |
| 07/01/2009 | EP2073828A2 Composition to treat or prevent gastrointestinal infection |
| 07/01/2009 | EP2073827A2 Multiple sclerosis therapy |
| 07/01/2009 | EP2073826A2 Sequential combination therapy |
| 07/01/2009 | EP2073820A2 Targeted polymeric prodrugs containing multifunctional linkers |
| 07/01/2009 | EP2073800A2 Ophthalmic compositions comprising diglycine |
| 07/01/2009 | EP1831252B1 Glp-1 analog fusion protein formulations |
| 07/01/2009 | EP1809315B1 Inhibition of tumor growth and metastasis by atf2-derived peptides |
| 07/01/2009 | EP1804816A4 Combination therapy comprising cloretazine(tm) |
| 07/01/2009 | EP1694354B1 Method for preventing and treating diabetes using neurturin |
| 07/01/2009 | EP1694314A4 Treatment and preventions of asthma |
| 07/01/2009 | EP1684782A4 Process for the synchronization of ovulation for timed breeding without heat detection |
| 07/01/2009 | EP1673633B1 Method for detecting feline immunodeficiency virus |
| 07/01/2009 | EP1666048A4 Method for producing insulin from a natural source and insulin |
| 07/01/2009 | EP1623719B1 Treatment of alzheimer's disease and cerebral amyloid angiopathy |
| 07/01/2009 | EP1565208B1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 07/01/2009 | EP1545577A4 Igf-binding protein-derived peptide or small molecule |
| 07/01/2009 | EP1534318A4 Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1465558B1 Use of cross-linked collagen for intervertebral disc treatment |
| 07/01/2009 | EP1359883A4 (psi)(epsilon)rack peptide composition and method for protection against tissue damage due to ischemia |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/01/2009 | EP1263939B1 18477, a human protein kinase and uses therefor |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | EP1124846B1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | EP1019068B1 Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms |
| 07/01/2009 | EP0915973B1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | CN101472603A Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene |
| 07/01/2009 | CN101472602A Use of fungal polysaccharides as pharmaceutical composition or food complements |
| 07/01/2009 | CN101472601A Non-natural amino acids and neurotensin analogues thereof |
| 07/01/2009 | CN101468200A Beauty treatment health-care capsule produced from deep sea fish collagen and preparation thereof |
| 07/01/2009 | CN101468199A Novel use of spider noxioussubstance and preparation thereof |
| 07/01/2009 | CN101468198A Soluble powder for treating mixed infection of livestock and poultry caused by bacteria and coccidian |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506844C Novel peptides |
| 07/01/2009 | CN100506311C Sustained delivery of an active agent using an implantable system |
| 07/01/2009 | CN100506284C Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 07/01/2009 | CN100506281C Method and device for feeding living cells into a biological body fluid |
| 07/01/2009 | CN100506280C Uptake of macromolecules |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506276C Preparation of cotton-seed polypeptide with anti-oxidant function |
| 07/01/2009 | CN100506275C Propagation increasing action of osteogenic growth peptide to hemopoietic progenitor cell and application |
| 06/30/2009 | USRE40812 Liquid pharmaceutical composition for nasal administration comprising calcitonin or an acid addition salt thereof and a bioavailability enhancing agent selected from citric acid, citric acid salt, and combination thereof, wherein combined concentration of all bioavailability enhancing agents is 10-25 mM |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7554021 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 06/30/2009 | US7553969 Substituted phenethylamine derivatives |
| 06/30/2009 | US7553962 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/30/2009 | US7553950 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers |
| 06/30/2009 | US7553941 Long-acting polypeptides and methods of producing same |
| 06/30/2009 | US7553940 comprising at least two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to an EPO (erythropoietin) peptide ; improving a biological half life of an hGH polypeptide |
| 06/30/2009 | US7553935 Modified vitamin K-dependent polypeptides |
| 06/30/2009 | US7553934 Enhanced membrane binding affinity; blood coagulation |
| 06/30/2009 | US7553933 Human p51 genes and gene products thereof |
| 06/30/2009 | US7553932 chronic arenavirus or a herpes virus; interleukin-10 receptor (IL-10R) |
| 06/30/2009 | US7553931 Convertase for use in identifying modulator for treatment and prevention of arthritis, kidney, inflammatory, heart and nervous system disorders |
| 06/30/2009 | US7553930 B-cell activation factor for use in diagnosis, prevention and treatment of glomerulonephritis and autoimmune diseases |
| 06/30/2009 | US7553929 Administering nuclear factor kappa beta (nf-kb)peptide nuclear localization sequence to inhibit import of stress-responsive transcription factor; septic shock, skin disorders, autoimmune diseases |
| 06/30/2009 | US7553928 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure |
| 06/30/2009 | US7553926 Therapeutic amino acid sequences for prevention and treatment of lymphadenopathy associated viral infection: viricides |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/30/2009 | US7553821 Methods for selectively modulating survivin apoptosis pathways |
| 06/30/2009 | US7553817 Ribose; enhancing ATP recovery and synthesis; increasing exercise capacity |
| 06/30/2009 | US7553814 Cancer drug target; useful in diagnostic, prophylactic, prognostic, of certain cancers |
| 06/30/2009 | US7553813 Methods and compositions for control of fetal growth via modulation of relaxin |
| 06/30/2009 | US7553812 Acyclovir-peptide analogs |
| 06/30/2009 | US7553811 administering a CD200 fusion protein; tranplant rejection, fetal loss, autoimmune disease, and allergies; immunosuppresant |
| 06/30/2009 | US7553810 Methods and compositions for sealing localized regions of damaged lung tissue to reduce overall lung volume, glue featuring an adhering moiety coupled to one or more other moieties including a cross-linkable moiety and/or one other adhering moiety; use in treating pulmonary conditions, emphysema, copd |
| 06/30/2009 | US7553659 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 06/30/2009 | US7553641 Tumour necrosis factor binding ligands |
| 06/30/2009 | US7553630 Detecting metalloproteinase inhibitor in sample of tissue, serum, urine, tumor; detectable label is a monoclonal antibody; radioimmunoassay, enzyme linked immunoassay |
| 06/30/2009 | US7553613 Coagulation, mechanical agitation; filtration |
| 06/30/2009 | US7553496 VEGF-A as an inhibitor of angiogenesis and methods of using same |
| 06/30/2009 | US7553494 WT1 fusion proteins |
| 06/30/2009 | US7553493 Chlamydia flagellar protein antigen |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |
| 06/30/2009 | CA2621950A1 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 06/30/2009 | CA2368812C Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 06/30/2009 | CA2324970C Improved immunodiagnostic assays using reducing agents |
| 06/30/2009 | CA2286399C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 06/30/2009 | CA2259421C Labelling and selection of molecules |
| 06/30/2009 | CA2236579C Methods and compositions for the delivery of monomeric proteins |
| 06/30/2009 | CA2222453C Therapeutic and drug screening methods for the treatment and prevention of neuronal disease |
| 06/30/2009 | CA2203480C Interferon conjugates |
| 06/30/2009 | CA2198917C Sustained release of peptides from pharmaceutical compositions |
| 06/30/2009 | CA2143486C Method of improving the immune response |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2108119C Glial mitogenic factors, their preparation and use |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/30/2009 | CA2057052C Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 06/25/2009 | WO2009079544A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | WO2009079452A2 Treatment and prevention of hiv infection |